Gevo, Inc. (NASDAQ: GEVO) reported second-quarter 2026 revenue of $46.5 million, up 7.1% from a year earlier and broadly in line with analyst expectations of $47.0 million. The company posted gross profit of $19.8 million, though that was down 24.3% year over year.
Profitability remained under significant pressure. Gevo reported an operating loss of $171.7 million, a much wider loss than a year ago, while net loss attributable to common shareholders reached $176.9 million. Diluted earnings per share came in at -$0.75, versus expectations for a smaller loss.
On the cash flow side, operating activities used $8.3 million in cash during the quarter, and the company spent $12.5 million on property, plant and equipment. Gevo ended the period with $58.1 million in cash and cash equivalents, while total liabilities declined to $209.8 million.
- Revenue: $46.5 million
- Gross profit: $19.8 million
- Operating loss: $171.7 million
- Net loss: $176.9 million
- Cash and equivalents: $58.1 million
The stock rose 10.4% after the market close following the earnings release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Gevo, Inc. Insider Trading Activity
Gevo, Inc. insiders have traded $GEVO stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $GEVO stock by insiders over the last 6 months:
- CHRISTOPHER MICHAEL RYAN (President & COO) has made 0 purchases and 4 sales selling 252,693 shares for an estimated $568,411.
- PATRICK R. GRUBER has made 0 purchases and 2 sales selling 344,032 shares for an estimated $549,004.
- GARY W. MIZE sold 107,100 shares for an estimated $250,078
- PAUL D BLOOM (CEO) has made 0 purchases and 2 sales selling 110,924 shares for an estimated $183,429.
- OLUWAGBEMILEKE YUSUF AGIRI (CFO) has made 0 purchases and 2 sales selling 94,986 shares for an estimated $144,727.
- ANDREW SHAFER (Chief Mktg Cust & Brnd Officer) has made 0 purchases and 5 sales selling 58,760 shares for an estimated $109,321.
- KIMBERLY T BOWRON (Chief of Staff) has made 0 purchases and 2 sales selling 40,571 shares for an estimated $66,220.
- LINDSAY CLINTON FITZGERALD (Chief Public Affairs Officer) sold 20,000 shares for an estimated $50,124
- DAVAAJARGAL GENDENJAMTS (VP Acctg and Treasurer) sold 4,293 shares for an estimated $6,118
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Gevo, Inc. Hedge Fund Activity
We have seen 66 institutional investors add shares of Gevo, Inc. stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 3,869,740 shares (-63.9%) from their portfolio in Q1 2026, for an estimated $10,564,390
- BANK OF AMERICA CORP /DE/ added 1,364,924 shares (+166.1%) to their portfolio in Q1 2026, for an estimated $3,726,242
- RENAISSANCE TECHNOLOGIES LLC added 1,342,400 shares (+153.8%) to their portfolio in Q1 2026, for an estimated $3,664,752
- CITADEL ADVISORS LLC added 1,125,603 shares (+119.8%) to their portfolio in Q1 2026, for an estimated $3,072,896
- GOLDMAN SACHS GROUP INC added 1,018,941 shares (+35.6%) to their portfolio in Q1 2026, for an estimated $2,781,708
- STATE STREET CORP added 641,544 shares (+7.6%) to their portfolio in Q1 2026, for an estimated $1,751,415
- NUVEEN, LLC removed 534,644 shares (-12.9%) from their portfolio in Q1 2026, for an estimated $1,459,578
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Gevo, Inc. Price Targets
Multiple analysts have issued price targets for $GEVO recently. We have seen 2 analysts offer price targets for $GEVO in the last 6 months, with a median target of $2.75.
Here are some recent targets:
- Manav Gupta from UBS set a target price of $2.0 on 05/22/2026
- Jeff Grampp from Northland Capital Markets set a target price of $3.5 on 04/16/2026
